interaction records 54 assistance programs 55 0 personal data stored
OmniRx › Tools › Generic competition check › Travoprost

Generic competition · all medicines · read 12 November 2026

Is there a generic of Travoprost, and who makes it?

Travoprost appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 7 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 12 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Travoprost2 dosage-form groups in the Orange Book
7generic makers listed
  1. Travoprost appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 7 generic makers listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came 12 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Solution/Drops, Ophthalmic

Four or more generic makers listed

Brand listed as marketed: Travatan Z. 7 generic makers with 7 generic products listed as marketed; the first generic approval is dated 1 March 2013.

200020052010201520202025203007brand 2001Chartwell Rx Sciences Llc, first approval 1 March 2013Apotex Inc, first approval 10 July 2015Mylan Pharmaceuticals Inc, first approval 7 July 2017Micro Labs Ltd, first approval 19 March 2021Gland Pharma Ltd, first approval 12 July 2024Somerset Therapeutics Llc, first approval 23 September 2024Alembic Pharmaceuticals Ltd, first approval 17 December 2025data datePatent 8323630 listed to expire 20 September 2027Patent 8388941 listed to expire 20 September 2027Patent 8268299 listed to expire 13 October 2029
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Chartwell Rx Sciences Llc1 March 20131
Apotex Inc10 July 20151
Mylan Pharmaceuticals Inc7 July 20171
Micro Labs Ltd19 March 20211
Gland Pharma Ltd12 July 20241
Somerset Therapeutics Llc23 September 20241
Alembic Pharmaceuticals Ltd17 December 20251

Patents and exclusivities still listed

  • 20 September 2027Patent 8323630 drug product
  • 20 September 2027Patent 8388941 drug product
  • 13 October 2029Patent 8268299 drug product

Implant, Intracameral

Brand listed, no generic listed as marketed

Brand listed as marketed: Idose Tr. No generic is listed as marketed.

202020252030203501brand 2023data datePatent 12201557 listed to expire 18 June 2030Patent 11426306 listed to expire 17 October 2030Patent 10206813 listed to expire 17 October 2030Patent 12201555 listed to expire 14 February 2031Exclusivity NP to 13 December 2026
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

  • 13 December 2026Exclusivity NP Idose Tr
  • 18 June 2030Patent 12201557 drug substance
  • 17 October 2030Patent 11426306 drug product
  • 17 October 2030Patent 10206813 drug product
  • 14 February 2031Patent 12201555 drug substance

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.